A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

NCT07358156 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

519

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: CKD-706
DRUG: US-Dupixent
DRUG: EU-Dupixent

Sponsor

Chong Kun Dang Pharmaceutical

Collaborators

Parexel